New cocktail of immune drugs shows promise for tough lung cancer
NCT ID NCT03337698
First seen Nov 03, 2025 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study looked at different combinations of immunotherapy drugs in 314 people with advanced non-small cell lung cancer. Some participants had not been treated before, while others had already tried chemotherapy and immunotherapy. The goal was to see if these new combos could shrink tumors or slow the cancer better than current options. The study is complete, and results help guide future treatment choices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL CELL LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barts Cancer Institute
London, E1 2AT, United Kingdom
-
Blacktown Hospital
Blacktown, New South Wales, 2148, Australia
-
Centre Georges Francois Leclerc
Dijon, 21000, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Chaim Sheba Medical Center
Ramat Gan, 52620-00, Israel
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Las Vegas, Nevada, 89169, United States
-
Fundación Jimenez Díaz
Madrid, 28040, Spain
-
Hopital de la Timone
Marseille, 13005, France
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Regional Universitario de Malaga
Málaga, 29010, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario HM Sanchinarro-CIOCC
Madrid, 28050, Spain
-
Hospital Universitario La Paz
Madrid, 280146, Spain
-
Institut De Cancerologie De L'Ouest
Saint-Herblain, 44115, France
-
Institut Régional du Cancer de Montpellier
Montpellier, 34298, France
-
Institut Universitaire du Cancer de Toulouse-Oncopole
Toulouse, 31100, France
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Peter Mac Callum Cancer Center
East Melbourne, Victoria, 3002, Australia
-
Rabin Medical Center
Petah Tikva, 4941492, Israel
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
University Hospitals Case Medical Center
Cleveland, Ohio, 44106, United States
-
University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC)
Songpa-gu, 05505, South Korea
Conditions
Explore the condition pages connected to this study.